FDA Inspection 1011944 — Guangzhou Baiyunshan Jingxiutang Pharmaceutical Co. Ltd.
The FDA completed an inspection of Guangzhou Baiyunshan Jingxiutang Pharmaceutical Co. Ltd. on May 12, 2017 in Foshan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 12, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Foshan (China)